X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare TTK HEALTHCARE with Glenmark Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TTK HEALTHCARE vs GLENMARK PHARMA - Comparison Results

GLENMARK PHARMA 
   Change

Glenmark's focus areas are dermatology, gynecology, pediatrics and diabetics. The domestic formulations business contributed about 35% to revenues in FY07. On the international front, besides exports to the semi-regulated markets, the company has bee... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TTK HEALTHCARE GLENMARK PHARMA TTK HEALTHCARE/
GLENMARK PHARMA
 
P/E (TTM) x 32.9 14.3 230.6% View Chart
P/BV x 6.1 3.8 160.8% View Chart
Dividend Yield % 0.5 0.3 149.7%  

Financials

 TTK HEALTHCARE   GLENMARK PHARMA
EQUITY SHARE DATA
    TTK HEALTHCARE
Mar-14
GLENMARK PHARMA
Mar-17
TTK HEALTHCARE/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs663993 66.8%   
Low Rs399729 54.7%   
Sales per share (Unadj.) Rs535.6325.5 164.5%  
Earnings per share (Unadj.) Rs15.939.3 40.6%  
Cash flow per share (Unadj.) Rs20.048.7 41.2%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Dividend yield (eoy) %0.80.2 324.2%  
Book value per share (Unadj.) Rs137.6159.2 86.4%  
Shares outstanding (eoy) m7.77282.17 2.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x1.02.6 37.5%   
Avg P/E ratio x33.321.9 152.0%  
P/CF ratio (eoy) x26.517.7 149.9%  
Price / Book Value ratio x3.95.4 71.4%  
Dividend payout %25.15.1 492.8%   
Avg Mkt Cap Rs m4,127242,991 1.7%   
No. of employees `0001.713.0 13.2%   
Total wages/salary Rs m60716,408 3.7%   
Avg. sales/employee Rs Th2,436.77,083.9 34.4%   
Avg. wages/employee Rs Th355.21,265.4 28.1%   
Avg. net profit/employee Rs Th72.5855.1 8.5%   
INCOME DATA
Net Sales Rs m4,16291,857 4.5%  
Other income Rs m61374 16.4%   
Total revenues Rs m4,22392,230 4.6%   
Gross profit Rs m19720,367 1.0%  
Depreciation Rs m322,644 1.2%   
Interest Rs m302,373 1.3%   
Profit before tax Rs m19715,724 1.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-810 0.0%   
Tax Rs m733,827 1.9%   
Profit after tax Rs m12411,088 1.1%  
Gross profit margin %4.722.2 21.4%  
Effective tax rate %37.024.3 152.1%   
Net profit margin %3.012.1 24.7%  
BALANCE SHEET DATA
Current assets Rs m1,62968,746 2.4%   
Current liabilities Rs m1,05827,027 3.9%   
Net working cap to sales %13.745.4 30.2%  
Current ratio x1.52.5 60.5%  
Inventory Days Days3085 35.0%  
Debtors Days Days3496 35.2%  
Net fixed assets Rs m55624,132 2.3%   
Share capital Rs m78282 27.5%   
"Free" reserves Rs m87844,643 2.0%   
Net worth Rs m1,06944,925 2.4%   
Long term debt Rs m15945,363 0.3%   
Total assets Rs m2,399117,639 2.0%  
Interest coverage x7.67.6 99.4%   
Debt to equity ratio x0.11.0 14.7%  
Sales to assets ratio x1.70.8 222.1%   
Return on assets %6.411.4 56.0%  
Return on equity %11.624.7 46.9%  
Return on capital %18.519.1 96.4%  
Exports to sales %0.80-   
Imports to sales %1.40-   
Exports (fob) Rs m33NA-   
Imports (cif) Rs m58NA-   
Fx inflow Rs m3356,152 0.1%   
Fx outflow Rs m638,084 0.8%   
Net fx Rs m-3048,068 -0.1%   
CASH FLOW
From Operations Rs m1276,574 1.9%  
From Investments Rs m-146-7,124 2.0%  
From Financial Activity Rs m225,432 0.4%  
Net Cashflow Rs m31,992 0.1%  

Share Holding

Indian Promoters % 65.4 48.3 135.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 6.9 53.6%  
FIIs % 5.2 34.4 15.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.8 10.5 245.7%  
Shareholders   12,723 56,727 22.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TTK HEALTHCARE With:   FDC LTD.  ALEMBIC LTD  WYETH LTD  AJANTA PHARMA  SUVEN LIFE  

Compare TTK HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Near Record High; Realty Stocks Bleed(Closing)

After opening the day on a strong note, share markets in India witnessed volatility during the last hour of trading session. However, they managed to end the day on a positive note.

Related Views on News

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Glenmark: Zetia Bolsters Sales and Profits (Quarterly Results Update - Detailed)

Oct 30, 2017

The 180-day exclusivity for Zetia enabled Glenmark to show strong growth in sales and profits during the quarter.

Glenmark Pharma: Lower Zetia Sales leads to Subdued Growth (Quarterly Results Update - Detailed)

May 18, 2017

Base price erosion in the US and lower Zetia sales impacts profits.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

The ONLY Thing You Need to Know About Bitcoin(The 5 Minute Wrapup)

Jan 6, 2018

You either want it or you want to get as far away from it as possible - but Bitcoin is just the noise masking the REAL opportunity. Read about it here...

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TTK HEALTHCARE SHARE PRICE


Jan 18, 2018 (Close)

TRACK TTK HEALTHCARE

  • Track your investment in TTK HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TTK HEALTHCARE

TTK HEALTHCARE - CIPLA COMPARISON

COMPARE TTK HEALTHCARE WITH

MARKET STATS